
Zantac and its generic form are being pulled off the shelves at all stores. The FDA has determined the low levels of a cancer-causing chemical is a greater risk than they previously thought. Previously, the FDA had said they detected low levels of a cancer-causing chemical in a sampling of the medication. However, they felt patients could continue using...